MORRIS TIMOTHY E 4
4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Aug 16, 2017
Insider Transaction Report
Form 4
MORRIS TIMOTHY E
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-08-14+250,000→ 250,000 totalExercise: $5.05Exp: 2027-08-13→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 250,000 shares shall vest on the one-year anniversary of August 14, 2017; and (ii) the remaining options shall vest as to one-twelfth of 250,000 shares at the end of each quarter over the next two years, commencing with the first quarter following the first anniversary of August 14, 2017.